- Home
- TAK vs ZS Comparison
TAK vs ZS Comparison
Compare TAK & ZS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | ZS |
|---|---|---|
| Founded | 1781 | 2007 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 52.0B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | TAK | ZS |
|---|---|---|
| Price | $14.53 | $230.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 34 |
| Target Price | N/A | ★ $323.73 |
| AVG Volume (30 Days) | ★ 2.6M | 2.4M |
| Earning Date | 01-29-2026 | 11-25-2025 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $29,846,840,032.00 | $2,833,272,000.00 |
| Revenue This Year | N/A | $26.93 |
| Revenue Next Year | $0.59 | $19.33 |
| P/E Ratio | $102.85 | ★ N/A |
| Revenue Growth | N/A | ★ 23.24 |
| 52 Week Low | $12.80 | $164.78 |
| 52 Week High | $15.69 | $336.99 |
Technical Indicators
Market Signals| Indicator | TAK | ZS |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 23.97 |
| Support Level | $14.20 | $237.77 |
| Resistance Level | $14.53 | $245.12 |
| Average True Range (ATR) | 0.13 | 6.82 |
| MACD | 0.02 | -0.74 |
| Stochastic Oscillator | 73.00 | 4.01 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About ZS Zscaler Inc.
Zscaler is a software-as-a-service, or SaaS, firm focusing on providing cloud-native cybersecurity solutions to primarily enterprise customers. Zscaler's offerings can be broadly partitioned into Zscaler Internet Access, which provides secure access to external applications, and Zscaler Private Access, which provides secure access to internal applications. The firm is headquartered in San Jose, California, and went public in 2018.